N
Nastaran Khalili
Researcher at Tehran University of Medical Sciences
Publications - 43
Citations - 387
Nastaran Khalili is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 9, co-authored 27 publications receiving 199 citations. Previous affiliations of Nastaran Khalili include Shahid Beheshti University of Medical Sciences and Health Services & Education and Research Network.
Papers
More filters
Journal ArticleDOI
Effects of lead and cadmium on the immune system and cancer progression.
Maryam Ebrahimi,Maryam Ebrahimi,Neda Khalili,Neda Khalili,Sepideh Razi,Sepideh Razi,Mahsa Keshavarz-Fathi,Mahsa Keshavarz-Fathi,Nastaran Khalili,Nastaran Khalili,Nima Rezaei,Nima Rezaei +11 more
TL;DR: This review investigated the effect of lead and cadmium, as pollutants that exist in many different parts of the human environment, on the immune system which is known to have a key role in the pathophysiology of cancer.
Journal ArticleDOI
Radiologic management of COVID-19: Preliminary experience of the iranian society of radiology COVID-19 consultant group (ISRCC)
Arash Mahdavi,Nastaran Khalili,Amir H. Davarpanah,Taraneh Faghihi,Ali Mahdavi,Sara Haseli,Ali Sabri,Shahram Kahkouee,Mohammad Ali Kazemi,Payam Mehrian,Farahnaz Falahati,Mehrdad Bakhshayeshkaram,Morteza Sanei Taheri +12 more
Journal ArticleDOI
Specific immunotherapy in ovarian cancer: a systematic review.
Soroush Alipour,Samaneh Zoghi,Nastaran Khalili,Armin Hirbod-Mobarakeh,Armin Hirbod-Mobarakeh,Leisha A. Emens,Nima Rezaei,Nima Rezaei +7 more
TL;DR: Overall there was not any significant difference in overall survival and recurrence-free survival between patients undergoing specific immunotherapy and those in control group and most of the studies reported a positive outcome from treatment with specific Immunotherapy, although this was not significant.
Journal ArticleDOI
The Association of CT-measured Cardiac Indices with Lung Involvement and Clinical Outcome in Patients with COVID-19.
Vahid Eslami,Alireza Abrishami,Ehsan Zarei,Nastaran Khalili,Zahra Baharvand,Morteza Sanei-Taheri +5 more
TL;DR: CT-measured cardiac indices might have predictive value regarding survival and extent of lung involvement in hospitalized patients with COVID-19 and could possibly be used for the risk stratification of these patients and for guiding therapy decision-making.
Journal ArticleDOI
Epicardial adipose tissue, inflammatory biomarkers and COVID-19: Is there a possible relationship?
Alireza Abrishami,Vahid Eslami,Zahra Baharvand,Nastaran Khalili,Somayeh Saghamanesh,Ehsan Zarei,Morteza Sanei-Taheri +6 more
TL;DR: Routine laboratory tests that represent status of inflammation can be used as cost-effective prognostic markers of COVID-19 and a significant association between EAT volume and other inflammatory biomarkers might explain the more severe disease in obese patients.